Phase 2 Study of Brentuximab Vedotin And Bevacizumab In

  • Gupta, Shilpa (PI)

Project: Research project

Project Details

Description

Phase 2 Study of Brentuximab Vedotin And Bevacizumab In Refractory CD-30 Positive Germ Cell Tumors
StatusActive
Effective start/end date8/1/167/31/22

Funding

  • Seattle Genetics, Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.